Advanced or Metastatic EP-NEC
1 clinical trials · Condition
◉ Watch Advanced or Metastatic EP-NEC
| Record | Firm | Date |
|---|---|---|
| Camrelizumab Combined With Chemotherapy and Apatinib for Extrapulmonary Neuroendocrine Carcinomas (NCT05142865) | Huazhong University of Science and Technology | 2022-01-14 |
Track Advanced or Metastatic EP-NEC automatically
Every clearance here is in the API, with alerts when new ones post.